BLU Stock - BELLUS Health Inc

BLU Stock Chart

BLU Profile

Bellus Health Inc (BLU) is a biopharmaceutical company that focuses on developing treatments for rare diseases. Its lead product candidate, BLU-5937, is being developed for the treatment of chronic cough, a common and debilitating condition that currently has no FDA-approved treatments. The company is also developing other drug candidates for various rare diseases. Bellus Health is headquartered in Laval, Quebec, Canada and is traded on the NASDAQ stock exchange.